中科院院士王建安：让脑机接口技术从实验室走向病房

Core Insights - Brain-computer interface (BCI) technology is at a critical juncture, transitioning from laboratory research to practical applications in medical settings, with significant potential for patient rehabilitation and quality of life improvement [1][2]. Industry Overview - The BCI market in China is projected to grow from 3.2 billion RMB in 2024 to 5.58 billion RMB by 2027, indicating a robust growth trajectory in the sector [1]. Clinical Advancements - Zhejiang University Second Affiliated Hospital has made notable clinical breakthroughs, including the successful implementation of a closed-loop spinal cord nerve interface surgery that enabled a paraplegic patient to perform various daily activities independently [2]. Challenges and Ethical Considerations - The BCI industry faces systemic challenges such as unclear pathways for technology transfer and a lack of ethical regulatory frameworks, particularly concerning issues like "brain privacy" and personal identity [2]. - There is a call for establishing national ethical guidelines for BCI research and application, emphasizing the need to protect brain data as a high-level personal biological information [2]. Recommendations for Development - It is suggested that the government establish entry mechanisms for BCI research and explore "quasi-clinical" pathways for institutions that achieve preliminary results, aiming to create a unique innovation ecosystem and regulatory paradigm in China [3].